Zafirlukast also proved to be a potential candidate for a therapeutic intervention in diabetes, since it enhanced insulin secretion and prompted the activation of Ca2+/calmodulin-dependent protein kinase II and extracellular signal-regulated kinase signaling. Here, INS is linked to diabetes mellitus.